Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference

Rhea-AI Summary

Guardant Health (Nasdaq: GH) will participate in the Morgan Stanley Virtual Healthcare Conference on September 15 at 8:45 a.m. Pacific Time. The event includes a fireside chat with company management, accessible via a live and archived webcast on their website. Guardant Health is a leader in precision oncology, utilizing proprietary blood tests and data analytics to enhance cancer treatment. Their offerings include the Guardant360® and GuardantOMNI® tests, primarily for advanced cancer patients, and the LUNAR program aimed at early-stage cancer detection and treatment.

REDWOOD CITY, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference.

Guardant Health’s management is scheduled for a fireside chat on Tuesday, September 15 at 8:45 a.m. Pacific Time / 11:45 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets, and advanced analytics. The Guardant Health Oncology Platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has launched liquid biopsy-based Guardant360^® and GuardantOMNI^® tests for advanced stage cancer patients. These tests fuel development of its LUNAR program, which aims to address the needs of early stage cancer patients with neoadjuvant and adjuvant treatment selection, cancer survivors with surveillance, asymptomatic individuals eligible for cancer screening and individuals at a higher risk for developing cancer with early detection.

Investor Contact:
Carrie Mendivil
investors@guardanthealth.com

Media Contact:
Anna Czene
press@guardanthealth.com

Courtney Carroll
courtney.carroll@uncappedcommunications.com 

FAQ

When will Guardant Health participate in the Morgan Stanley Virtual Healthcare Conference?

Guardant Health will participate in the Morgan Stanley Virtual Healthcare Conference on September 15 at 8:45 a.m. Pacific Time.

How can I access the Guardant Health conference presentation?

You can access the live and archived webcast of the Guardant Health presentation on their website in the 'Investors' section.

What is Guardant Health known for?

Guardant Health is known for its precision oncology solutions, including blood tests that improve cancer treatment outcomes and reduce healthcare costs.

What products does Guardant Health offer for cancer patients?

Guardant Health offers the Guardant360® and GuardantOMNI® tests for advanced cancer patients, as well as the LUNAR program for early-stage cancer detection.

What is the focus of the LUNAR program by Guardant Health?

The LUNAR program by Guardant Health focuses on early-stage cancer detection and treatment options for at-risk individuals and cancer survivors.